Advertisement
Screener

INOGEN, INC. (INGN) Research and Development Expense

2.8 / 5 stars · 68/120 Roast Me

INOGEN, INC. Research and Development Expense

INOGEN, INC. (INGN) reported Research and Development Expense of $5.87 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-07

  • INOGEN, INC. research and development expense for the quarter ending 2026-06-30 was $5.87M, a 12.71% increase year-over-year.
  • INOGEN, INC. research and development expense for the quarter ending 2026-03-31 was $5.10M, a 26.35% increase year-over-year.
  • INOGEN, INC. research and development expense for the quarter ending 2025-12-31 was $5.32M, a 9.87% decline year-over-year.
  • INOGEN, INC. research and development expense for the quarter ending 2025-09-30 was $4.84M, a 37.58% increase year-over-year.
  • INOGEN, INC. research and development expense for fiscal 2025 was $19.40M, a 10.23% decline from fiscal 2024.
  • INOGEN, INC. research and development expense for fiscal 2024 was $21.61M, a 3.69% increase from fiscal 2023.
  • INOGEN, INC. research and development expense for fiscal 2023 was $20.84M, a 5.03% decline from fiscal 2022.
  • INOGEN, INC. research and development expense for fiscal 2022 was $21.94M, a 32.38% increase from fiscal 2021.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2026-06-30$5.87M
10-Q · filed 2026-08-07
$10.97M
10-Q · filed 2026-08-07
$16.28M
derived: sum of 3 quarters · filed 2026-08-07
$21.12M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$5.10M
10-Q · filed 2026-05-08
$10.41M
derived: sum of 2 quarters · filed 2026-05-08
$15.25M
derived: sum of 3 quarters · filed 2026-05-08
$20.46M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$5.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$10.16M
derived: sum of 2 quarters · filed 2026-02-27
$15.37M
derived: sum of 3 quarters · filed 2026-08-07
$19.40M
10-K · filed 2026-02-27
2025-09-30$4.84M
10-Q · filed 2025-11-06
$10.05M
derived: sum of 2 quarters · filed 2026-08-07
$14.08M
10-Q · filed 2025-11-06
$19.98M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$5.21M
10-Q · filed 2026-08-07
$9.24M
10-Q · filed 2026-08-07
$15.14M
derived: sum of 3 quarters · filed 2026-08-07
$18.66M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$4.03M
10-Q · filed 2026-05-08
$9.93M
derived: sum of 2 quarters · filed 2026-05-08
$13.45M
derived: sum of 3 quarters · filed 2026-05-08
$19.07M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$5.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$9.42M
derived: sum of 2 quarters · filed 2026-02-27
$15.03M
derived: sum of 3 quarters · filed 2026-02-27
$21.61M
10-K · filed 2026-02-27
2024-09-30$3.52M
10-Q · filed 2025-11-06
$9.13M
derived: sum of 2 quarters · filed 2025-11-06
$15.71M
10-Q · filed 2025-11-06
$22.43M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$5.62M
10-Q · filed 2025-08-08
$12.19M
10-Q · filed 2025-08-08
$18.91M
derived: sum of 3 quarters · filed 2026-02-27
$23.40M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31$6.58M
10-Q · filed 2025-05-08
$13.29M
derived: sum of 2 quarters · filed 2026-02-27
$17.78M
derived: sum of 3 quarters · filed 2026-02-27
$22.07M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31$6.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$11.20M
derived: sum of 2 quarters · filed 2026-02-27
$15.50M
derived: sum of 3 quarters · filed 2026-02-27
$20.84M
10-K · filed 2026-02-27
2023-09-30$4.49M
10-Q · filed 2024-11-08
$8.78M
derived: sum of 2 quarters · filed 2024-11-08
$14.13M
10-Q · filed 2024-11-08
$20.06M
derived: sum of 4 quarters · filed 2025-02-28
2023-06-30$4.29M
10-Q · filed 2024-08-07
$9.64M
10-Q · filed 2024-08-07
$15.57M
derived: sum of 3 quarters · filed 2025-02-28
$20.15M
derived: sum of 4 quarters · filed 2025-02-28
2023-03-31$5.34M
10-Q · filed 2024-05-08
$11.28M
derived: sum of 2 quarters · filed 2025-02-28
$15.86M
derived: sum of 3 quarters · filed 2025-02-28
$21.92M
derived: sum of 4 quarters · filed 2025-02-28
2022-12-31$5.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28
$10.52M
derived: sum of 2 quarters · filed 2025-02-28
$16.58M
derived: sum of 3 quarters · filed 2025-02-28
$21.94M
10-K · filed 2025-02-28
2022-09-30$4.58M
10-Q · filed 2023-11-09
$10.64M
derived: sum of 2 quarters · filed 2023-11-09
$16.01M
10-Q · filed 2023-11-09
$20.69M
derived: sum of 4 quarters · filed 2024-03-01
2022-06-30$6.06M
10-Q · filed 2023-08-08
$11.43M
10-Q · filed 2023-08-08
$16.11M
derived: sum of 3 quarters · filed 2024-03-01
$19.87M
derived: sum of 4 quarters · filed 2024-03-01
2022-03-31$5.36M
10-Q · filed 2023-05-05
$10.05M
derived: sum of 2 quarters · filed 2024-03-01
$13.80M
derived: sum of 3 quarters · filed 2024-03-01
$17.93M
derived: sum of 4 quarters · filed 2024-03-01
2021-12-31$4.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
$8.44M
derived: sum of 2 quarters · filed 2024-03-01
$12.56M
derived: sum of 3 quarters · filed 2024-03-01
$16.58M
10-K · filed 2024-03-01
2021-09-30$3.75M
10-Q · filed 2022-11-03
$7.88M
derived: sum of 2 quarters · filed 2022-11-03
$11.89M
10-Q · filed 2022-11-03
$15.57M
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30$4.12M
10-Q · filed 2022-08-04
$8.14M
10-Q · filed 2022-08-04
$11.81M
derived: sum of 3 quarters · filed 2023-02-24
$15.32M
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31$4.01M
10-Q · filed 2022-05-05
$7.69M
derived: sum of 2 quarters · filed 2023-02-24
$11.20M
derived: sum of 3 quarters · filed 2023-02-24
$14.49M
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31$3.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$7.18M
derived: sum of 2 quarters · filed 2023-02-24
$10.47M
derived: sum of 3 quarters · filed 2023-02-24
$14.08M
10-K · filed 2023-02-24
2020-09-30$3.51M
10-Q · filed 2021-11-04
$6.80M
derived: sum of 2 quarters · filed 2021-11-04
$10.41M
10-Q · filed 2021-11-04
$14.03M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$3.29M
10-Q · filed 2021-08-04
$6.89M
10-Q · filed 2021-08-04
$10.52M
derived: sum of 3 quarters · filed 2022-02-24
$13.16M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$3.60M
10-Q · filed 2021-05-04
$7.23M
derived: sum of 2 quarters · filed 2022-02-24
$9.87M
derived: sum of 3 quarters · filed 2022-02-24
$11.34M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$3.63M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$6.26M
derived: sum of 2 quarters · filed 2022-02-24
$7.73M
derived: sum of 3 quarters · filed 2022-02-24
$9.40M
10-K · filed 2022-02-24
2019-09-30$2.64M
10-Q · filed 2020-11-04
$4.10M
derived: sum of 2 quarters · filed 2020-11-04
$5.77M
10-Q · filed 2020-11-04
$7.51M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$1.47M
10-Q · filed 2020-08-04
$3.14M
10-Q · filed 2020-08-04
$4.88M
derived: sum of 3 quarters · filed 2021-02-24
$6.97M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$1.67M
10-Q · filed 2020-05-05
$3.41M
derived: sum of 2 quarters · filed 2021-02-24
$5.51M
derived: sum of 3 quarters · filed 2021-02-24
$7.28M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$1.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$3.84M
derived: sum of 2 quarters · filed 2021-02-24
$5.61M
derived: sum of 3 quarters · filed 2021-02-24
$7.03M
10-K · filed 2021-02-24
2018-09-30$2.10M
10-Q · filed 2019-11-05
$3.87M
derived: sum of 2 quarters · filed 2019-11-05
$5.29M
10-Q · filed 2019-11-05
$6.66M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$1.77M
10-Q · filed 2019-08-07
$3.19M
10-Q · filed 2019-08-07
$4.56M
derived: sum of 3 quarters · filed 2020-02-25
$5.93M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$1.42M
10-Q · filed 2019-05-07
$2.79M
derived: sum of 2 quarters · filed 2020-02-25
$4.16M
derived: sum of 3 quarters · filed 2020-02-25
$5.42M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$2.74M
derived: sum of 2 quarters · filed 2020-02-25
$4.00M
derived: sum of 3 quarters · filed 2020-02-25
$5.31M
10-K · filed 2020-02-25
2017-09-30$1.38M
10-Q · filed 2018-11-06
$2.63M
derived: sum of 2 quarters · filed 2018-11-06
$3.94M
10-Q · filed 2018-11-06
$5.16M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$1.26M
10-Q · filed 2018-08-07
$2.57M
10-Q · filed 2018-08-07
$3.79M
derived: sum of 3 quarters · filed 2019-02-26
$5.13M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$1.31M
10-Q · filed 2018-04-30
$2.52M
derived: sum of 2 quarters · filed 2019-02-26
$3.88M
derived: sum of 3 quarters · filed 2019-02-26
$5.25M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$1.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$2.57M
derived: sum of 2 quarters · filed 2019-02-26
$3.94M
derived: sum of 3 quarters · filed 2019-02-26
$5.11M
10-K · filed 2019-02-26
2016-09-30$1.35M
10-Q · filed 2017-11-07
$2.73M
derived: sum of 2 quarters · filed 2017-11-07
$3.90M
10-Q · filed 2017-11-07
$5.12M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30$1.38M
10-Q · filed 2017-08-03
$2.55M
10-Q · filed 2017-08-03
$3.77M
derived: sum of 3 quarters · filed 2018-02-27
$4.89M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$1.17M
10-Q · filed 2017-05-09
$2.39M
derived: sum of 2 quarters · filed 2018-02-27
$3.51M
derived: sum of 3 quarters · filed 2018-02-27
$4.49M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$1.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$2.34M
derived: sum of 2 quarters · filed 2018-02-27
$3.32M
derived: sum of 3 quarters · filed 2018-02-27
$4.18M
10-K · filed 2018-02-27
2015-09-30$1.12M
10-Q · filed 2016-11-03
$2.09M
derived: sum of 2 quarters · filed 2016-11-03
$2.95M
10-Q · filed 2016-11-03
$3.62M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$975.00K
10-Q · filed 2016-08-04
$1.84M
10-Q · filed 2016-08-04
$2.50M
derived: sum of 3 quarters · filed 2017-02-28
$3.30M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31$863.00K
10-Q · filed 2016-05-09
$1.53M
derived: sum of 2 quarters · filed 2017-02-28
$2.33M
derived: sum of 3 quarters · filed 2017-02-28
$3.21M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$665.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$1.46M
derived: sum of 2 quarters · filed 2017-02-28
$2.34M
derived: sum of 3 quarters · filed 2017-02-28
$2.98M
10-K · filed 2017-02-28
2014-09-30$798.00K
10-Q · filed 2015-11-10
$1.68M
derived: sum of 2 quarters · filed 2015-11-10
$2.31M
10-Q · filed 2015-11-10
$2.89M
derived: sum of 4 quarters · filed 2016-03-14
2014-06-30$879.00K
10-Q · filed 2015-08-11
$1.51M
10-Q · filed 2015-08-11
$2.10M
derived: sum of 3 quarters · filed 2016-03-14
$2.77M
derived: sum of 4 quarters · filed 2016-03-14
2014-03-31$635.00K
10-Q · filed 2015-05-12
$1.22M
derived: sum of 2 quarters · filed 2016-03-14
$1.89M
derived: sum of 3 quarters · filed 2016-03-14
$2.53M
derived: sum of 4 quarters · filed 2016-03-14
2013-12-31$581.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14
$1.25M
derived: sum of 2 quarters · filed 2016-03-14
$1.90M
derived: sum of 3 quarters · filed 2016-03-14
$2.40M
10-K · filed 2016-03-14
2013-09-30$674.00K
10-Q · filed 2014-11-12
$1.31M
derived: sum of 2 quarters · filed 2014-11-12
$1.82M
10-Q · filed 2014-11-12
2013-06-30$640.00K
10-Q · filed 2014-08-12
$1.14M
10-Q · filed 2014-08-12
2013-03-31$503.00K
10-Q · filed 2014-05-13
2012-12-31$2.26M
10-K · filed 2015-04-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B